Recipient Professor Enrico Petretto from Duke-NUS is spearheading groundbreaking research to develop new drugs for lung disease and uncover new therapeutic targets for kidney
News & Articles
Recipient Associate Professor Lena Ho spearheads groundbreaking research to develop first-in-class therapeutics to target inflammatory diseases Collaboration between 65LAB and Duke-NUS aims to advance
Read about the key role of 65LAB in Singapore’s burgeoning ecosystem, as it seeks to advance academic projects through the steps towards company formation.
Discover more about the way-markers for a successful translational roadmap from the investor’s perspective Discover more from Evotec
